Abstract
Purpose of Review
Genomics has ushered in a phase of predictive, preventive and personalized medicine (PM), and several attempts are being made to detect genetic variations that are responsible for susceptibility to diseases and varied response to medications, however, have met with only a limited success. Ancient Indian system of medicine, Ayurveda, strongly emphasize on personalized patient care under the concept of Prakriti (phenotype-based human constitution). We would therefore like to put forward a new dimension of PM—the ‘Prakriti-based medicine’ bearing testable molecular and genetic correlates.
Recent Findings
Current investigations in the field of genomics, PM and Ayurveda have inspired many researchers and started in-depth deliberation on how Prakriti (phenotype-based Ayurveda constitution) is associated with the field of genomics, biochemistry, psychology, physiology and therapeutics. Various genotypes have also been correlated with Prakriti. Studies have shown wide range of utilities of Prakriti assessment in therapeutics, i.e. from predicting disease susceptibility of an individual, prevention of impending diseases, early diagnosis through screening of the high risk, rational drug designing, customization of therapy (drug, diet and lifestyle) and health maintenance.
Summary
Ayurvedic Prakriti-based treatment resonates with PM and pharmacogenomics and holds potential and promise for future predictive or preventive medicine. Further studies are warranted towards integrating or complementing genomics and contemporary medical science with Prakriti and explore the future possibilities.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Decrypting human genome has steered current biomedical science towards a hope of revivifying contemporary symptomatic treatment approaches into personalized and predictive therapies depending upon an individual’s genetic makeup. Investigations in the past decade aptly introduced and mandated in-depth deliberation on how ‘personalized medicine (PM)’ is providing an impetus in shaping the future of medicine. PM or individualized medicine is a rapidly advancing therapeutic approach owing to its potential to transform and strengthen the healthcare system. The basic principle of PM is to tailor the treatment strategies based on each individual’s clinical, genomic, epigenomic, proteomic and environmental profile [1]. Though the PM is gaining popularity in the past decade, the concept is not new as it bears resemblance with the time-tested ancient medical systems, viz. Ayurveda, traditional Chinese medicine and traditional Iranian medicine. These medical systems follow individualized treatment approach as per the human constitutional types defined as per their own well-defined wisdoms [2].
The concept of PM or predictive medicine has its roots date back to 1500 BCE in age-old traditional Indian medicine, Ayurveda, which has a stratified approach as its basic doctrine for personalizing the treatment under Purusham Purusham Vikshya (an individualized approach) principle [3]. The seeds of predictive and personalized medicine were sown by an ancient Ayurveda treatise—Charaka Samhita, which quotes that: ‘Every individual is distinct from another and hence should be treated as a different entity. As many variations are there in the universe, all are seen in human beings’ [4]. Prakriti is the fundamental constitution of a person, formed at the time of birth, differentiates variations according to the Beeja (genetic) and three doshas or Tridosha (body humours, viz. Vata (kinetic), Pitta (metabolic) and Kapha (potential)), influence into three extreme geno-psycho-somatotypes or birth constitutions or body types, i.e. Vata Prakriti, Pitta Prakriti and Kapha Prakriti, and remains invariant throughout lifetime [4]. Some scholars have roughly related these Vata, Pitta and Kapha body constitutions with Sheldon somatotypes of twentieth century, i.e. ectomorphic, mesomorphic and endomorphic body types respectively [5].
Prakriti, the notable basic construct of Ayurvedic epistemology, elucidates the biological variability (at cellular and genomic level) that is observed in different individuals. Prakriti of each person determines the response differently when exposed to the same stimuli and makes every individual a distinct entity [6••]. Modern medicine classifies the human population based on geographical origin, ethnicity, race and other factors, while Prakriti classification distinguishes and characterizes a person apart from others based on morphological, physiological or psychological traits and is independent of racial, ethnic or geographical factors. The Tridosha work in harmony and regulate each other to maintain homeostasis, equilibrium, healthy body and mind. Any imbalance of Tridosha can lead to disorders as per the Prakriti of an individual. For instance, Pitta Prakriti persons are mentioned to be more susceptible to peptic ulcers, high blood pressure and skin disorders; a Vata Prakriti person to backache, joint aches and crackling joints; while individuals with Kapha Prakriti are more likely to develop obesity, diabetes and atherosclerosis. Various common health disorders and the susceptibility of different Prakriti types are stipulated in Table 1. Development and advancement of different health ailments with their subtypes are mentioned to be depending upon the derivation and manner of perturbation of Tridosha, and the treatment is aimed to maintain the Tridosha in homeostasis [3, 7]. Likewise, modern systems biology exemplified by translational P4 medicine surmises the convergence of multi-scalar genetic, cellular, physiological and environmental networks to speculate phenotypic outcomes of perturbations [8].
Present review provides comprehensive understanding on PM from evidence-based Ayurvedic perspective and how Prakriti (phenotype-based human constitution) is associated with the field of genomics, biochemistry, physiology and therapeutics.
Assessment of Prakriti
Over 150 anatomical and physical activity-related characteristic features are examined for Prakriti assessment, where physiological and psychological parameters are extrapolated based on the responses of a person and past history [9•]. As per Ayurvedic classical texts, the distinct characters of three basic Prakriti types and their predisposition to diseases are stipulated in Fig. 1.
In order to avert misinterpretation of the clinical features during examination, recent and infrequent change of internal or external environment is also taken into consideration. It is an intricate task to infer Prakriti from such enormous range of features. Though clinical evaluation of Prakriti is non-empirical, it can be assessed and substantiated through advanced machine learning techniques, which may ease precise Prakriti prediction [10•]. For determination of Prakriti, along with classical Ayurvedic methods such as pulse detection and standard questionnaires (to identify characteristic features of individual’s Prakriti), software like AyuSoft (mainly for Prakriti of adults) and PRS-IPA (mainly for Prakriti of children) are also being developed [11, 12]. Based on the assessment of Prakriti, therapy is planned in Ayurveda clinical practice. Ayurvedic mode of personalized treatment approach based on three Prakriti types is different from modern medical system and the same is portrayed in Fig. 2.
Pharmacogenomics Vis-à-Vis Ayurgenomics
Pharmacogenomics, a subset of Prakriti-based medicine, deals with genetic interactions with drugs, explains the inter-individual variations in drug responses (by correlating gene expression or single nucleotide polymorphism (SNP)) and helps PM approach to optimize rational drug therapy thereby ensures maximum efficacy with minimal adverse effects [13].
The variations in response to drug therapy due to differences in acetylation of drugs are well-known exemplar of genetic polymorphism. These demographic and ethnic differences affecting the phenotypic variability may be related to Ayurvedic concept of factors responsible for Prakriti, which include Jati Prasakta, Kula Prasakta and Deshanupatini types of Prakriti [4]. Ayurgenomics is an integrative approach utilizing genomics and principles of Ayurveda, aiming at discovery of predictive markers for preventive and PM by establishing the correlation between DNA and Prakriti. Better understanding of human genome and SNP has aided to understand the scientific basis of individual variation, which appear analogous with the concept of Prakriti-based medicine, i.e. Ayurgenomics [14•]. This Ayurvedic approach of phenotypic classification of three constitutional types seems to bear similarities with pharmacogenomics.
Genomic Counterparts of Prakriti
The correlation of the concept of Prakriti with genomics was hypothesized over a decade ago [14•]. To substantiate the genetic and molecular basis of Prakriti, several dedicated attempts correlate Prakriti classification with genetic information and association of SNPs. Recent report has found differential DNA methylation signatures in three distinct Prakriti types, thus, demonstrated the epigenetic basis of Ayurvedic human classification [15••]. Genetic connotation of Prakriti demonstrated a link between Human Leukocyte Antigen (HLA) alleles and Prakriti type, ascertaining a rationale and preliminary experimental support for the hypothesis of a linkage between HLA alleles and Tridosha theory of human Prakriti types [16]. A study detected reasonable connection between HLA type and Prakriti type. It affirmed complete absence of the HLA DRB1*02 allele in the Vata Prakriti and of HLA DRB1*13 in the Kapha type, and higher allele frequency of HLA DRB1*10 in the Kapha than in the Pitta and Vata types [6••]. A study has reported a significant correlation between CYP2C19 genotype and Pitta Prakriti. [17]. A study reported a link of EGLN1 gene partaking in high altitude adaptation, which was explored through genetic analysis of three Prakritis. The TT genotype of rs479200 which was more frequent in Kapha Prakriti and correlated with higher expression of EGLN1 was linked with patients suffering from high-altitude pulmonary edema, while it was less frequent in Pitta and nearly absent in residents of high altitude [18].
A recent study pointed out linkage of both specific genes and genomic variations with the diverse phenotypes representative of distinct Prakriti types. They classified three Prakritis and substantiated the classification by using genome-wide SNP markers. The study conducted genome-wide SNP analysis (Affymetrix, 6.0) of 262 well-classified individuals of three Prakritis. After 106 permutations, significant variation was found in 52 SNPs (p ≤ 1 × 10–5) amongst Prakritis with no any stratification-related confounding effect. Principal component analysis (PCA) of these SNPs classified 262 individuals into Vata, Pitta and Kapha groups irrespective of their ancestry. The finding was further validated with 297 Indian people samples with known ancestry and noticed that PGM1 correlates with phenotype of Pitta as quoted in the Charaka Samhita suggesting the genetic basis of Prakriti [19••]. Thus, several researchers made attempts to correlate the genomes with Ayurvedic Prakriti concept and the same is highlighted in Fig. 3.
Drug Administration, Drug Safety and Prakriti
Ayurveda strongly emphasize that prior prescribing medication several factors should be analysed to avoid drug-related adverse effects, such as age, season and time of administration, pathological stage of disease, digestive power, individual humours (dosha) and individual constituent (Prakriti) [20]. Idiosyncratic drug reactions are aberrant or bizarre or hypersensitivity response of a person to a drug that is unrelated to the pharmacological effect of a drug and many a times the cause is unknown [21]. As per ‘Host vulnerability theory’, the effects of a drug vary from person to person [22]. The same concept has been explicated in Ayurveda as Prakriti or human constitution.
Studies also reveal that the different Prakriti persons may have dissimilar rates of drug metabolism which relates to drug metabolizing enzyme (DME) polymorphism as well. CYP gene polymorphisms are known to regulate drug tolerance and metabolism [23]. Researchers have correlated metabolic variability with CYP2C19 genetic variability and HLA gene polymorphism to explicate the pharmacogenomics concept with distinct Prakritis [6••, 17]. In this interesting correlation between CYP2C19 genotypes and Prakriti, Extensive Metabolizer genotype was present in Pitta Prakriti and Slow Metabolizer genotype was found in Kapha Prakriti. This validates the Ayurvedic concepts that Kapha Prakriti individuals are more prone to metabolic and cardiovascular disorders; accordingly, ancient scholars of Ayurveda advocate moderate exercise to Kapha Prakriti individuals to maintain Kapha in equilibrium and reduce the tendencies to develop diabetes and obesity [24, 25].
Several reports of adverse reaction of drugs and non-responsiveness to certain drugs are being witnessed [26,27,28]. Phenotypic classification of individuals as per Prakriti is also important in decreeing drug safety. In several examples, specific drugs are contraindicated in particular Prakriti type, e.g. Bhallataka (Semecarpus anacardium) and Hingu (Ferula narthex) are having hot potency and Pitta vitiating property therefore contraindicated in Pitta constitution individuals or Pitta dominant diseases [29]. Similarly, Dhatura (Datura metel) is having Vata vitiating potency, hence not advised in Vata constitution persons or Vata dominant diseases [30]. Certain formulations are suitable for individuals of specific constitution, e.g. Ksheerbala Taila is indicated for Vata Prakriti, Kushmandavleha is indicated for Pitta Prakriti and Amrit Bhallataka is suitable for Kapha Prakriti individuals. Also, certain dosage forms are advised to certain Prakriti persons, e.g. Taila Kalpana (medicated oils) are usually indicated in Vata Prakriti, Ksheerpaka (medicated milk) and Hima Kalpana (cold infusions) in Pitta Prakriti and Asava-Arishta (fermented extracts) are advised in Kapha Prakriti individuals [31]. These examples clearly suggest that, consideration of Ayurvedic individualistic or constitution-based treatment approach while drug administration have effective role with respect to safety and efficacy.
Further exploration of Ayurvedic concept of constitution-based distinctive treatment plan could provide new directions for detecting the causal metabolic variability responsible for variations in drug response. These variations can be embraced under idiosyncrasy. Accordingly, rational drug designing should also emphasize on individual patients and sub-groups of patients.
Biochemical and Clinical Basis of Prakriti
The recent past has witnessed an extensive exploration on Prakriti apropos its genomic and biochemical correlations and subsequent clinical applications. The concept is claimed to have wide range of utilities in therapeutics, i.e. from predicting disease susceptibility of an individual, diagnosis, therapy and health maintenance (Fig. 4) [5, 16, 18, 32••].
Interestingly, in genome wide association studies (GWAS), over 2000 SNPs have been identified to be associated with disease susceptibility. Understanding of Prakriti can help to surmount the current limitation of clinical heterogeneity in molecular genetic analysis of complex traits. A single extensive study conducted under Council of Scientific and Industrial Research (CSIR) led Indian Genome Variation (IGV) consortium project explored the genetic landscape of IGV related to disease and response to drugs [33, 34]. Individuals with three contrasting Prakritis showed strong contrast with respect to haematological parameters, body mass index (BMI), blood groups and at genome-wide expression levels [19••].
In a microarray profiling study, functional classes of genomes exhibiting differential expression amongst three Prakritis were found to be markedly involved with the bioprocesses like transport, regulating the protein kinase activity, immune responses and regulating the blood coagulation [32••]. A strong over-expression of genes was found in genes regulating cellular division and nucleocytoplasmic transport in Vata Prakriti, genes regulating immune surveillance in Pitta Prakriti and genes regulating anabolism in Kapha Prakriti individuals. It was interesting to note that 31% of the differentially expressed genes in these Prakriti types showed association with complex and monogenic diseases (in Online Mendelian Inheritance in Man (OMIM) and Genetic Association Database (GAD)) [32••].
Efforts have also been made to relate different Prakriti and their biochemical and transcriptomic profiles [35]. A study suggested discrete causal pathways for rheumatoid arthritis aetiology in Prakriti-based subgroups, thus supporting the Ayurvedic doctrines of Prakriti and PM. It related Prakriti classification with inflammatory and oxidative stress-related genes, e.g. inflammation-regulating genes like IL1β (C-C-C haplotype, p = 0.0005, OR = 3.09) and CD40 (rs4810485 allelic, p = 0.04, OR = 2.27) were found to be the determinants in Vata subgroup, while oxidative stress pathway genes in Pitta (SOD3 rs699473, p = 0.004, OR = 1.83; rs2536512 p = 0.005; OR = 1.88 and PON1 rs662, p = 0.04, OR = 1.53) and Kapha (SOD3 rs2536512, genotypic, p = 0.02, OR = 2.39) subgroups. Thus, Ayurgenomics viewpoint may have promising role in biomarker discovery for complex diseases [36]. Prakriti-based immunophenotyping of normal persons demonstrated striking dissimilarity in CD14, CD25 and CD56 marker expressions amongst Prakriti types. Increased CD25 and CD56 levels in Kapha Prakriti may signify better potential to exhibit immune response, which concord with the classical description in Ayurveda [37]. Serotoninergic receptor gene 5HTR 2A showed a significantly high allele frequency in Kapha Prakriti. HLA genes are known to have profound role in defence response to infections and on immunogenic tendency to various diseases, and its high frequency was found in Kapha Prakriti [4].
Adenosine diphosphate (ADP)-induced maximal platelet aggregation (MPA) was found higher in Vata-Pitta Prakriti individuals and they responded better to lower dose of aspirin compared with other Prakriti types, which is suggestive of role of Prakriti identification in individualizing treatment or predicting disease susceptibility [38•]. Another study found the lesser intelligent quotient (IQ) of Vata Prakriti individuals in comparison with Pitta Prakriti and lesser IQ of Pitta Prakriti than Kapha Prakriti. Therefore, Prakriti assessment can offer decisive guidelines in direction of career selection [39]. In a work, Prakriti was assessed in patients with established Parkinson’s disease and the findings showed that the incidence of Parkinson’s was higher in those with Vata Prakriti [40].
Another study investigated how walking (aerobic isotonic exercise) affected the physiological variants in diabetics as per Prakriti and found a strong association between blood pressure, pulse pressure, respiratory rate and certain biochemical parameters with the Prakriti of an individual at certain physiological conditions [41].
A study showed that the levels of serum uric acid, serum zinc, serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT) and the common risk factors for cardiovascular disorders such as triglycerides (TG), low density lipid (LDL), very low density lipid (VLDL), low density lipid/high density lipid (LDL/HDL) ratio were significantly higher, whereas HDL level significantly lower in Kapha Prakriti individuals in comparison with other Prakriti type. They also found higher serum prolactin and prothrombin time levels in Vata Prakriti, and higher level of haematological parameters, viz. haemoglobin, packed cell volume (PCV) and red blood cells (RBC) in Pitta Prakriti individuals in comparison with other Prakriti [32••]. These observations were also supported by several studies, where Kapha dominant Prakriti subjects show a higher prevalence/susceptibility to obesity, type 2 diabetes, hyperuricemia, higher lipid profile and BMI values, cardiovascular risks and atherosclerosis as compared with Vata and Pitta dominant Prakriti [13, 42, 43]. Another study found significantly higher level of TG, VLDL and LDL and significantly lower HDL in Vata-Kapha Prakriti in comparison with other body constitutions [42].
One study reported Kapha-Pitta Prakriti individuals to be more susceptible to developing dyslipidaemia and related comorbidities [44]. In such Prakriti individuals, timely and effective lifestyle interventions can be planned to prevent lipid-related disorders. Another study assessed effect of aerobic exercise on obese type-2 diabetics and found more decline in serum insulin level and homeostatic model assessment of insulin resistance (HOMA-IR) in Kapha Prakriti than Pitta types; additionally, the increase in insulin sensitivity (HOMA-%S) was more in Kapha Prakriti individuals than Pitta type [45].
A multicenter study on healthy subjects found that Kapha Prakriti individuals were having higher BMI as opposed to Vata Prakriti [46]. A anthropometric study on infants found that Vata Prakriti infants were having lower weight, lean and thin (lower head circumference and chest circumference), and short stature (lower crown heel length), while it was maximum in Kapha Prakriti infants [47]. Researchers also studied correlation of different Prakriti types and blood groups of infants and found maximum occurrence of Vata Prakriti individuals in A+ blood group, Pitta type in O+ blood group, Kapha type in B+ blood group and Vata-Kapha Prakriti in AB+ blood group [48].
A recent cross-sectional study analysed milk (for fats, solid non-fats, density, proteins, lactose, freezing-point, conductivity and pH) of lactating mothers as per Prakriti and found that the milk composition varied according to different Prakriti [49]. Several works have identified association of patterns of gut microbiota with host variables, viz. geography, age, dietary habits and Prakriti phenotypes.
An interesting study investigated healthy human gut microbiome structure within three distinct Prakriti groups from a genetically homogenous cohort and discovered differentially abundant taxa. 16S rRNA gene-based microbial community profiling was carried out. Despite overall uniform composition of gut microbial community, healthy individuals of distinct Prakriti types exhibited enrichment of specific bacteria. Bacteroidetes and Firmicutes (gut microbial components) showed differential abundance within Prakriti types [50•]. A recent report also suggested significance of Prakriti types as a potential stratifier of the gut microbiome [51].
A study through Ayurgenomics approach established a genetic link between EGLN1 and VWF in a constitution-specific manner which could modulate thrombosis/bleeding susceptibility and outcomes of hypoxia. A combination of derived EGLN1 allele (high altitude pulmonary edema (HAPE) associated) and ancestral VWF allele (thrombosis associated) was significantly high in Kapha Prakriti individuals as compared with Pitta Prakriti [52•].
Ageing is a relentless and unidirectional phenomenon of life [53]. In Pitta Prakriti person, aggravated functions of Pitta can be observed such as increased metabolism/basal metabolic rate (BMR), biotransformation and physiological functions, which may change the related physiology following which the anatomical structures are also affected with regard to decay and degeneration. It is thus suggested that Pitta Prakriti persons are prone to untimely or premature manifestations of ageing like graying of hairs, skin wrinkles and hair fall [54]. Though, scientific investigations are warranted to validate these concepts.
Thus, considering all these evidences, it can be inferred that the principles of Ayurgenomics have plausible impact on phenotype-genotype correlation, drug-discovery, pharmacogenomics and PM [16, 17].
Perspectives and Future Directions
In Ayurvedic therapeutics, focus is given to individualize the diet, lifestyle and medication as per different Prakriti classification to attain a healthy life. It is evident from this report that each specific disease poses as risk factor or show predominance to specific type of Prakriti individuals, thus said concept holds potential and promise for future predictive or preventive medicine [4, 32••, 55]. As a step further, newborn genetic screening for Prakriti, if encouraged, can open up prospects of planning suitable diet, lifestyles and environmental settings that may help to prevent the diseases that a particular Prakriti type is prone to. For example, if one could know that a newborn has Kapha Prakriti then right from the starting, the child can be motivated to engage in sports and outdoor activities as Kapha Prakriti individuals are more prone to develop metabolic disorders such as diabetes, obesity and cardiovascular diseases. Likewise, if the child is having Pitta Prakriti, spicy/acidic food may not be served to that child, as Pitta Prakriti persons have more tendencies to suffer with gastric ulcers, bleeding disorders, acne and related health ailments [56]. Recent initiatives like Ayurgenomics TRISUTRA consortium may help to identify differently susceptible and drug responsive population and thus Prakriti concept can strengthen the efficiency of drug discovery and development programs [9•].
The pharmacokinetics and dynamics (PKPD) of the drugs may also vary according to high inter-individual variability amongst the different Prakriti types, which could result in varied clinical response to these drugs, though more systematic studies are warranted for profound understanding. Several attempts have been made to validate and evaluate the applicability and future possibilities of Prakriti concept, though more extensive works are warranted to render the obtained results into reliable, generalizable, reproducible and applicable inferences.
Conclusions
To sum up, Ayurveda system of medicine emphasize on personalized patient care and its concept of Prakriti resonates with PM/pharmacogenomics. Compelling evidences suggest that the concept of Prakriti is not only based of phenotypes, rather it is a genotype determined phenotypic expression. Further exploration in this area can help the researchers to unveil genes that may contribute to system level differences in normal individuals and could lead to differential disease susceptibility. As the Prakriti-based research is still in its infantile stage, further studies on integrating or complementing genomics and contemporary medical science with Prakriti are highly anticipated, which may provide new insights towards achieving the goal of personalized healthcare.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Annadurai K, Danasekaran R, Mani G. Personalized medicine: a paradigm shift towards promising health care. J Pharm Bioallied Sci. 2016;8:77–8.
Jafari S, Abdollahi M, Saeidnia S. Personalized medicine: a confluence of traditional and contemporary medicine. Altern Ther Health Med. 2014;20(5):31–40.
Acharya YT. Sushruta, Sushruta Samhita, Sharirasthana, Garbhavyakarana, 4/78. 7th ed. Varanasi: Chaukhambha Orientalia; 2002. p. 362.
Amin H, Sharma R, Vyas M, Vyas H. Genomic counterparts to human constitution (Prakriti). Indian J Anc Med Yoga. 2014;4:29–37.
Rizzo-Sierra CV. Ayurvedic genomics, constitutional psychology and endocrinology: the missing connection. J Altern Complement Med. 2011;17:465–8.
•• Patwardhan B, Kalpana J, Arvind C. Classification of human population based on HLA gene polymorphism and the concept of Prakriti in Ayurveda. J Altern Complement Med. 2005;11:349–53 First study to demonstrate genomic connotation to Prakriti classification.
Patwardhan B, Joshi K, Ghodke Y. Genetic basis to concept of Prakriti. Curr Sci. 2006;90:896.
Flores M, Glusman G, Brogaard K, Price ND, Hood L. P4 medicine: how systems medicine will transform the healthcare sector and society. Perinat Med. 2013;10(6):565–76.
• Prasher B, Varma B, Kumar A, Khuntia BK, Pandey R, Narang A, et al. Ayurgenomics for stratified medicine: TRISUTRA consortium initiative across ethnically and geographically diverse Indian populations. J Ethnopharmacol. 2017;197:274–93 The review suggested significant differences between Prakriti types in 28 SNPs and how Ayurgenomics concept can augment the efficiency of drug discovery and development programs.
• Tiwari P, Kutum R, Sethi T, Shrivastava A, Girase B, Aggarwal S, et al. Recapitulation of Ayurveda constitution types by machine learning of phenotypic traits. PLoS One. 2017;12(10):e0185380 The study assessed and substantiated Prakriti through advanced machine learning techniques.
Ayosoft: a decision support system for ayurveda, developed by C-DAC [Internet]. [cited 12 May 2018]. Available from: http://www.cdac.in/index.aspx?id¼hi_dss_ayusoft.)
Niraj S, Singh P, Sangeeta G, Singh S, Singh BM. Basics for the development of prototype research software relevant to infants’ Prakriti assessment for Vikriti management and possible future disorders. Int J Res Ayurveda Pharm. 2017; 8(Suppl 1).
Amin H, Sharma R. Biochemical and anthropometric profiles of different Prakriti (Ayurvedic constitution) patients of non-insulin dependent diabetes mellitus. J Obes Metab Res. 2015;2:120–4.
• Patwardhan B. AyuGenomics–integration for customized medicine. Indian J Nat Prod Resour. 2003;19:6–23 First report to hypothesize concept of Prakriti with genomics.
•• Rotti H, Mallya S, Kabekkodu SP, et al. DNA methylation analysis of phenotype specific stratified Indian population. J Transl Med. 2015;13:151 The study demonstrated DNA methylation differences between Prakriti types and supported epigenetic basis of Ayurvedic constitution classification.
Patwardhan B, Bodeker G. Ayurvedic genomics: establishing a genetic basis for mind-body typologies. J Altern Complement Med. 2008;14:571–6.
Ghodke Y, Joshi K, Patwardhan B. Traditional medicine to modern pharmacogenomics: Ayurveda Prakriti type and CYP2C19 gene polymorphism associated with the metabolic variability. Evid Based Complement Alternat Med. 2011;2011:249528–5. https://doi.org/10.1093/ecam/nep206.
Agarwal S, Negi S, Jha P, Singh PK, Stobdan T, Pasha MA, et al. EGLN1 involvement in high altitude adaptation revealed through genetic analysis of extreme constitution types defined in Ayurveda. Proc Natl Acad Sci U S A. 2010;107:18961–6.
•• Govindaraj P, Nizamuddin S, Sharath A, Jyothi V, Rotti H, Raval R, et al. Genome-wide analysis correlates Ayurveda Prakriti. Sci Rep. 2015;5:15786 The study performed genome-wide SNP analysis of different Prakriti individuals, found 52 SNPs distinct between Prakritis and suggested its genetic basis.
Kaiyadeva. Kaiyadeva of Kaiyadevanighantu. In: Sharma P.V., Sharma G.P., editors. 1st ed. Chaukhambha orintalia; Varanasi (UP): 2009. 64, 188.
Roth Robert A, Luyendyk, Maddox James P, Ganey EP. Perspectives in pharmacology inflammation and drug idiosyncrasy—is there a connection? Am Soc Pharmacol Exp Ther. 2003;1:1–8.
Zimmerman HJ Hepatotoxicity Dis Mon 1993;39:675–787.
Zhou SF, Liu JP, Chowbay B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev. 2009;41:89–95.
Sharma H, Chandola HM. Ayurvedic concept of obesity, metabolic syndrome, and diabetes mellitus. J Altern Complement Med. 2011;17:549–52.
Tipton CM. Susruta of India, an unrecognized contributor to the history of exercise physiology. J Appl Physiol. 2008;104:1553–6.
Sharma R, Galib R, Prajapati PK. Good pharmacovigilance practises: accountability of Ayurvedic pharmaceutical companies. Anc Sci Life. 2017;36(3):167–9.
Sharma R, Hazra J, Prajapati PK. Knowledge and awareness of pharmacovigilance among Ayurveda physicians in Himachal Pradesh. Anc Sci Life. 2017;36(4):234–5.
Sharma R. Pharmacovigilance obligations of Ayurveda physicians and pharma sector. Indian J Ethnophytopharmaceuticals. 2016;2(4):4–6.
Sharma PV, Nighantu P editor. 1st ed. vol. 20. Chaukhamba Samskruta Pratistana; Varanasi (UP): 2004. p. 156.
Pandey GS. Bhavaprakshnighantu of Bhavamisra. Chaukhambabharati Academy; Varanasi (UP): 2004. p. 317.
Sumantran VN, Tillu G. Ayurvedic pharmaceutics and insights on personalized medicine. Progress in Traditional and Folk Herbal Medicine 2011;13–52.
•• Prasher B, Negi S, Aggarwal S, Mandal AK, Sethi TP, Deshmukh SR, et al. Whole genome expression and biochemical correlates of extreme constitutional types defined in Ayurveda. J Transl Med. 2008;6:48 First study to explore whether the different constitution types as described in Ayurveda have molecular correlates.
Olivier C, Williams-Jones B, Godard B, Mikalson B, Ozdemir V. Personalized medicine, bioethics and social responsibilities: re-thinking the pharmaceutical industry to remedy inequities in patient care and international health. Curr Pharm Pers Med. 2008;6:108–20.
Gupta PD. Pharmacogenetics, pharmacogenomics and Ayurgenomics for personalized medicine: a paradigm shift. Indian J Pharm Sci. 2015;77:135–41.
Sachidanandam R, Weissman D, Schmidt C, Kakol JM, Stein LD, Marth G, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature. 2001;409:928–33.
Juyal RC, Negi S, Wakhode P, Bhat S, Bhat B, et al. Potential of Ayurgenomics approach in complex trait research: leads from a pilot study on rheumatoid arthritis. PLoS One. 2012;7:e45752.
Rotti H, Guruprasad KP, Nayak J, Kabekkodu SP, Kukreja H, Mallya S, et al. Immunophenotyping of normal individuals classified on the basis of human dosha Prakriti. J Ayurveda Integr Med. 2014;5:43–9.
• Bhalerao S, Deshpande T, Thatte U. Prakriti (Ayurvedic concept of constitution) and variations in platelet aggregation. BMC Complement Altern Med. 2012;12:248 The study demonstrated that platelet aggregatory response varied in the different Prakriti types.
Karande LA, Tawalare KA, Tawalare KK. Evaluation of Buddhimatta according to DehaPrakriti in contemporary intelligence quotient (iq). Unique J Ayurvedic Herb Med. 2013;1:37–40.
Manyam BV, Kumar A. Ayurvedic constitution (Prakriti) identifies risk factor of developing medicine, Parkinson’s disease. J Altern Complement Med. 2013;19:644–9.
Tiwari S, Gehlot S, Tiwari SK, Singh G. Effect of walking (aerobic isotonic exercise) on physiological variants with special reference to Prameha (diabetes mellitus) as per Prakriti. AYU. 2012;33(1):44–9.
Mahalle NP, Kulkarni MV, Pendse NM, Naik SS. Association of constitutional type of ayurveda with cardiovascular risk factors, inflammatory markers and insulin resistance. J Ayurveda Integr Med. 2012;3:150–7.
Amin H, Sharma R. Biochemical and anthropometric profile of obese subjects of different Prakriti (constitution) at Jamnagar District, Gujarat, India. Int J Clin Exp Physiol. 2015;2:16–22.
Khatri M, Sharma US. A comparative study of changes in lipid profile in different age groups w.s.r. Prakriti. Int J Ayurveda Pharma Res. 2013;1(2):31–7.
Kavita P, Sangeeta G, Kamlakar T. Effect of aerobic exercise on anthroprometric and metabolic parameters in obese type-2 diabetics with reference to specific body constitution (Prakriti). Int J Res Ayurveda Pharm. 2012;3(5):659–63.
Rotti H, Raval R, Anchan S, Bellampalli R, Bhale S, Bharadwaj R, et al. Determinants of Prakriti, the human constitution types of Indian traditional medicine and its correlation with contemporary science. J Ayurveda Integr Med. 2014;5:167–75.
Srivastava N, Gehlot S, Singh S, Singh BM. Do the anthropometric parameters vary as per Prakriti (physical constitution) of infants. Int J Innov Knowl Concepts. 2017;5(12):107–15.
Niraj S, Sangeeta G, Sanjay S, Singh BM. Association of Prakriti and blood groups of infants in respect to blood groups of parents. Int J Innov Knowl Concepts. 2018;6(7):225–8.
Singh D, Singh BM, Gehlot S. A cross sectional study on analysis of human milk as per Prakriti (psychosomatic constitution). Curr Res Nutr Food Sci. 2020;8(1):245–55.
• Chauhan NS, Pandey R, Mondal AK, et al. Western Indian rural gut microbial diversity in extreme Prakriti endo-phenotypes reveals signature microbes. Front Microbiol. 2018;9:118 The study established variability in gut microbial flora amongst different Prakriti types.
Jnana A, Murali TS, Guruprasad KP, Satyamoorthy K. Prakriti phenotypes as a stratifier of gut microbiome: a new frontier in personalized medicine? J Ayurveda Integr Med. 2020. https://doi.org/10.1016/j.jaim.2020.05.013.
• Aggarwal S, Gheware A, Agrawal A, et al. Combined genetic effects of EGLN1 and VWF modulate thrombotic outcome in hypoxia revealed by Ayurgenomics approach. J Transl Med. 2015;13:184 The work established a genetic link between EGLN1 and VWF in Prakriti-specific manner through Ayurgenomics approach.
Sharma R, Martins N. Telomeres, DNA damage and ageing: potential leads from Ayurvedic Rasayana (anti-ageing) drugs. J Clin Med. 2020;9(8):2544.
Purvya MC, Meena MS. A review on role of prakriti in aging. Ayu. 2011;32(1):20.
Sethi TP, Prasher B, Mukerji M. Ayurgenomics: a new way of threading molecular variability for stratified medicine. ACS Chem Biol. 2011;6:875–80.
Dey S, Pahwa P. Prakriti and its associations with metabolism, chronic diseases, and genotypes: possibilities of new born screening and a lifetime of personalized prevention. J Ayurveda Integr Med. 2014;5:15–24.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
There is no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Precision Medicine and Pharmacogenomics
Rights and permissions
About this article
Cite this article
Sharma, R., Prajapati, P.K. Predictive, Preventive and Personalized Medicine: Leads From Ayurvedic Concept of Prakriti (Human Constitution). Curr Pharmacol Rep 6, 441–450 (2020). https://doi.org/10.1007/s40495-020-00244-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40495-020-00244-3